Table 1.
CET | Equation | Construction principle | Symmetry | Positivity | Scaling | Diagonality | Maximal combination effect EmaxAB | Inhibitory form |
---|---|---|---|---|---|---|---|---|
Competitive | Equation (18) | DRBKa | Yes | Yes | Yes | Yes | max {EmaxA;EmaxB} | Yes |
Uncompetitive | Equation (22) | DRBKa | No | Yes | Yes | – | (1+ β′)EmaxA | Yes for β′ ≤ 0 |
Non-competitive | Equation (24) | DRBKa | No | Yes | Yes | – | (1+ β′)EmaxA | Yes for β′ ≤ 0 |
Loewe | Equation (29) | ADDb | Yes | Yes | Yes | Yes | Emax | Yes |
Bliss | Equation (33) | ADDb | Yes | Yes | Yes | Yes | Emax | Yes |
Greco | Equation (37) | ADDb | Yes | No | Yes | Yes | Emax | Yes |
Summation | Equation (39) | EmpSUMc | Yes | Yes | Yes | No | EmaxA + EmaxB | No |
Inhibitory | Equation (42) | IDRd | Yes | Yes | No | No | ImaxA + ImaxB − ImaxAImaxB | – |
Stimulation | Equation (43) | IDRd | Yes | Yes | No | No | EmaxA + EmaxB + EmaxAEmaxB | No |
Drug-receptor binding kinetics
Additive approaches
Empirical summation approaches
Indirect response models